Overview

The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects

Status:
Completed
Trial end date:
2018-11-08
Target enrollment:
Participant gender:
Summary
This study was conducted to prove the efficacy of BST-104 in patients with mild to moderate FD.
Phase:
Phase 3
Details
Lead Sponsor:
Seoul National University Bundang Hospital